株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アレルギー性喘息:世界の治験動向

Asthma Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 321697
出版日 ページ情報 英文 1655 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.91円で換算しております。
Back to Top
アレルギー性喘息:世界の治験動向 Asthma Global Clinical Trials Review, H1, 2017
出版日: 2017年04月30日 ページ情報: 英文 1655 Pages
概要

当レポートでは、アレルギー性喘息治療薬に関する治験の最新動向について分析しており、主要7カ国 (G7) および新興7カ国 (E7) における治験件数と、被験者数、有望なスポンサー、治験に携わっている主な企業や機関、有望な薬剤の情報をまとめています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:呼吸器系疾患治療薬の治験におけるアレルギー性喘息の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患治療薬の治験におけるアレルギー性喘息の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

アレルギー性喘息治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Asthma Global Clinical Trials Review, H1, 2017" provides an overview of Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Asthma to Respiratory Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Asthma to Respiratory Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Asthma Therapeutics Clinical Trials 28
  • Prominent Drugs 29
  • Latest Clinical Trials News on Asthma 30
  • Mar 06, 2017: AB Science announces completion of patient recruitment for phase 3 study in severe persistent asthma 30
  • Mar 06, 2017: GSK's MUSCA study shows Nucala (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype 30
  • Mar 02, 2017: Cynata Advances Development of Cymerus MSCs for the Treatment of Asthma 31
  • Feb 27, 2017: ALKs ACARIZAX Data Results in Significant Change to the GINA Asthma Management Strategy 31
  • Feb 23, 2017: Positive Results for Relvar Ellipta Lung Function Study in Patients with Well-Controlled Asthma 32
  • Feb 14, 2017: Allergy Therapeutics Announces Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval 32
  • Feb 13, 2017: AnaptysBio to Present Data from ANB020 Program at Two Upcoming Medical Meetings 33
  • Clinical Trial Profile Snapshots 34

Appendix 1652

  • Abbreviations 1652
  • Definitions 1652
  • Research Methodology 1653
  • Secondary Research 1653
  • About GlobalData 1654
  • Contact Us 1654
  • Source 1655

List of Tables

List of Tables

  • Asthma Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Asthma Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
  • Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
  • Proportion of Asthma to Respiratory Clinical Trials, G7 Countries (%), 2017* 15
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Asthma to Respiratory Clinical Trials, E7 Countries (%), 2017* 18
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Asthma Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
  • Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures

List of Figures

  • Asthma Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 20
Back to Top